• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

BD’s IV catheters plant in Utah marks 70 years

September 29, 2026 By Conor Hale

BD's manufacturing plant in Sandy, Utah
The Sandy manufacturing site. [Photo courtesy of BD]
BD (NYSE:BDX) is celebrating the 70th birthday of its major manufacturing facility in Utah, which the company said produces billions of molded components each year.

Located in the town of Sandy just south of Salt Lake City, the site was founded in 1956 under Deseret Pharmaceuticals. BD acquired the plant in 1986, and today it’s home to a 650,000-square-foot facility that employs more than 1,000 people.

The company said it has invested more than $100 million in the past five years to boost its extrusion and tubing capabilities, which produce hundreds of millions of sterile peripheral intravenous catheters annually for the U.S. and international shipments.

“For 70 years, generations of Sandy employees have brought tremendous skill, pride and purpose to work that touches patient care every day,” BD’s worldwide president of medication delivery solutions, Eric Borin, said in a statement.

As one of its longest-running facilities, BD recognized 34 employees with more than 40 years of service, as well as 80 who have spent at least 25 years with the company.

“Their commitment to safety, quality, innovation and operational excellence helps ensure clinicians can rely on the products made here during some of the most fundamental moments in care delivery,” Borin added. “I am incredibly proud of this team and the impact they make for patients, healthcare providers and the community.”

As part of the celebration, BD will make a $10,000 grant to Utah’s Maliheh Free Clinic, which the company first partnered with in 2024. The company also noted that since 2022, BD and Sandy employees have contributed more than $170,000 to local organizations such as FIRST Robotics Utah, Make-A-Wish Utah and the Mabuhay Deseret Foundation. In addition, BD said it works with local schools through internship programs and site visits focused on medical technology and advanced manufacturing careers.

“BD’s legacy in Utah and in medtech worldwide is tremendous, and we’re immensely proud of all that they’ve built in Sandy over the past 70 years,” said Jefferson Moss, commissioner of the state government’s office of economic development. “In Utah, we’re scaling our ability to manufacture essential technologies and products that our country needs, and companies like BD and its talented workforce deserve our congratulations as thanks as they advance these efforts.”

Filed Under: Distribution, Vascular Tagged With: BD

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS